| Heather Larue Edmondson, FNP | |
|
102 3rd St, Belmont, MS 38827 | |
| (662) 454-3401 | |
| Not Available |
| Full Name | Heather Larue Edmondson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 102 3rd St, Belmont, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093225070 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 1-163717 (Alabama) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 902349 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tishomingo Health Services Inc | Iuka, MS | Hospital |
| Red Bay Hospital | Red bay, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boa Vida Hospital Of Aberdeen Ms Llc | 0244505840 | 43 |
News Archive
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases.
A study finds physicians veer toward more profitable services amid lower Medicare fees. Meanwhile, Humana tests a patient-centered medical home program in Florida and a former Virginia official is chosen to take on a top position at the Centers for Medicaid and Medicare Services.
Abbott today announced the initiation of ABSORB II, the first randomized, controlled, multi-center clinical trial to evaluate the safety, efficacy and performance of the Absorb™ bioresorbable vascular scaffold (BVS) compared to the company's XIENCE PRIME™ Everolimus Eluting Coronary Stent System.
An already promising initiative to assist start-up firms that commercialize technologies associated with the Quality of Life Technology (QoLT) Center is now expanding thanks to a three-year, $1.5 million Innovation Award from the National Science Foundation's (NSF) Division of Engineering Education and Centers.
› Verified 3 days ago
| Entity Name | Boa Vida Hospital Of Aberdeen Ms Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710405741 PECOS PAC ID: 0244505840 Enrollment ID: O20171128003460 |
News Archive
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases.
A study finds physicians veer toward more profitable services amid lower Medicare fees. Meanwhile, Humana tests a patient-centered medical home program in Florida and a former Virginia official is chosen to take on a top position at the Centers for Medicaid and Medicare Services.
Abbott today announced the initiation of ABSORB II, the first randomized, controlled, multi-center clinical trial to evaluate the safety, efficacy and performance of the Absorb™ bioresorbable vascular scaffold (BVS) compared to the company's XIENCE PRIME™ Everolimus Eluting Coronary Stent System.
An already promising initiative to assist start-up firms that commercialize technologies associated with the Quality of Life Technology (QoLT) Center is now expanding thanks to a three-year, $1.5 million Innovation Award from the National Science Foundation's (NSF) Division of Engineering Education and Centers.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Heather Larue Edmondson, FNP Po Box 813, Belmont, MS 38827-0813 Ph: (662) 454-3401 | Heather Larue Edmondson, FNP 102 3rd St, Belmont, MS 38827 Ph: (662) 454-3401 |
News Archive
Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases.
A study finds physicians veer toward more profitable services amid lower Medicare fees. Meanwhile, Humana tests a patient-centered medical home program in Florida and a former Virginia official is chosen to take on a top position at the Centers for Medicaid and Medicare Services.
Abbott today announced the initiation of ABSORB II, the first randomized, controlled, multi-center clinical trial to evaluate the safety, efficacy and performance of the Absorb™ bioresorbable vascular scaffold (BVS) compared to the company's XIENCE PRIME™ Everolimus Eluting Coronary Stent System.
An already promising initiative to assist start-up firms that commercialize technologies associated with the Quality of Life Technology (QoLT) Center is now expanding thanks to a three-year, $1.5 million Innovation Award from the National Science Foundation's (NSF) Division of Engineering Education and Centers.
› Verified 3 days ago
Whitney Bonner Sparks, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 26 3rd St, Belmont, MS 38827 Phone: 662-454-4520 Fax: 662-454-4521 | |
Lacy Diane Estes, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 26 3rd St, Belmont, MS 38827 Phone: 662-454-4520 Fax: 662-454-4521 | |
Dr. Toni Armstrong, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8 Front St, Belmont, MS 38827 Phone: 662-454-1170 | |
Angela James, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 26 3rd St, Belmont, MS 38827 Phone: 662-454-7170 | |
Lisa Collums Rhea, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8 Front St, Belmont, MS 38827 Phone: 662-454-1170 Fax: 662-454-1062 | |
Misty Leigh Glidewell, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8 Front St, Belmont, MS 38827 Phone: 662-454-1170 Fax: 662-454-1062 |